SecBot SecBot

MED

MEDIFAST INC
NYSE· Miscellaneous Food Preparations & Kindred Products· Inc. DE· CIK 0000910329 Consumer & Retail
$11.87 −0.30 (−2.47%)
Oct 23 4:00 PM ET · prev $12.17
Market cap
$136.1M
Micro cap
Median target
🔒 Subscribers only
1 year
−5.3%
from $12.54 · Oct 24
30 days
−0.4%
from $11.92
52-week range
$9.45–13.15
−10% from high · low Jul 23
Avg volume 20D
109.7K
shares / day
Short interest
1.05M
≈9.4% of shares · −43.4%
Days to cover
7.3
at average volume
Insider net
+$1.4M
3 buyers · 1 seller · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
8
analyzed by SecBot
SecBot read BULLISH 7 reports · 90 days
Balance 0 bearish · 3 bullish · 4 neutral oldest → newest, height = score
Avg score ·High conf. 3/7
Strongest BULLISH Director Kiai Parsa purchased ~120K shares of MEDIFAST (MED) for ~$1.42M over a 7-day window (Aug 19-26…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    3 insiders bought $1.7M at an average $11.68. 1 insider sold $226.3K.

  • InstitutionsMIXED

    Q2 2026: 14 added (0 new), 13 trimmed or exited.

  • Short sellersCOVERING

    Short interest −43.4% to 1.05M shares. 7.3 days to cover, ≈9.4% of shares.

  • TrendDOWNTREND

    0% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
ROYAL BANK OF CANADATRIM53—
CHARLES SCHWAB INVESTMENT MANAGEMENT INCTRIM396,996$4.2M
BlackRock, Inc.TRIM369,503$3.9M
AMERICAN CENTURY COMPANIES INCADD318,911$3.4M
GOLDMAN SACHS GROUP INCADD243,085$2.6M
JANE STREET GROUP, LLCADD164,881$1.7M
GEODE CAPITAL MANAGEMENT, LLCTRIM121,071$1.3M
D. E. Shaw & Co., Inc.TRIM92,345$979.8K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Feb 2026

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Feb 19, 2026Stephens & Co.
MAINTAIN
MAINTAINEqual-Weight
Feb 19, 2025DA Davidson
MAINTAIN
MAINTAINNeutral
Nov 5, 2024DA Davidson
UPGRADE
UPGRADENeutral
Jul 22, 2024DA Davidson
MAINTAIN
MAINTAINUnderperform
Jun 5, 2024DA Davidson
DOWNGRADE
DOWNGRADEUnderperform
Apr 30, 2024DA Davidson
MAINTAIN
MAINTAINNeutral

Insider ledger

Form 4
$1.7M
bought · 3 insiders
$226.3K
sold · 1 insider
+1.7%
vs their $11.68 cost
DateInsiderTypeValue
Sep 29, 2026
Chard Daniel R
Director
SELL$112.0K
Sep 28, 2026
Chard Daniel R
Director
SELL$114.3K
Aug 26, 2026
Kiai Parsa
Director
BUY$514.7K
Aug 26, 2026
Kiai Parsa
Director
BUY$14.4K
Aug 24, 2026
Kiai Parsa
Director
BUY$50.5K
Aug 24, 2026
Kiai Parsa
Director
BUY$1.4K
Aug 20, 2026
Kiai Parsa
Director
BUY$13.6K
Aug 20, 2026
Kiai Parsa
Director
BUY$487.1K

Earnings setup

Estimates

Revision history: 🔒 Fresh data — subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data — subscribers only
Next Q🔒 Fresh data — subscribers only
Current FY🔒 Fresh data — subscribers only
Next FY🔒 Fresh data — subscribers only

Short side

FINRA· Sep 30, 2026
1,053,225
shares short
-43.4%
vs prior settlement
7.3
days to cover
≈9.4%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 26, 2026 SEC
🔒 Fresh report (last 24h) — subscribers only
Oct 26, 2026 Earnings calendar
🔒 Fresh data — subscribers only
Oct 15, 2026 Press
Medifast issued a press release debunking menopause weight gain myths and promoting its Trilivy metabolic health…
Impact 2/10
Oct 6, 2026 Press
Medifast published a press release discussing the science behind weight regain and how its Trilivy system addresses it…
Impact 2/10
Sep 29, 2026 Insider
Chard Daniel R sold 9,544 shares
Director @ $11.73 ($112.0K)
Sep 28, 2026 Insider
Chard Daniel R sold 9,545 shares
Director @ $11.98 ($114.3K)
Aug 28, 2026 SEC
Director Kiai Parsa purchased ~120K shares of MEDIFAST (MED) for ~$1.42M over a 7-day window (Aug 19-26, 2026) at…
INSIDER-BUY — Impact 6/10
Aug 26, 2026 SEC
Director Kiai Parsa made a series of open-market purchases totaling $895K across multiple days, representing…
INSIDER-BUY — Impact 6/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 26, 2026
Earnings date
🔒 Fresh data — subscribers only
Oct 15, 2026
Announcement
Why Is Weight Loss Different During Menopause? Common Myths Debunked
Trilivy debunks five menopause weight loss myths, showing why lean mass preservation and coaching matter more than eating less and moving more....
Oct 6, 2026
Announcement
Why Do You Keep Gaining Weight Back After Losing It
Trilivy identifies five research-backed drivers of weight regain, from slowed metabolism and hormonal shifts to lost lean mass and habit breakdown.
Oct 1, 2026
Announcement
What Are the 5 Signs of Poor Metabolic Health Adults May Overlook?
Trilivy outlines five overlooked signs of poor metabolic health, from rising visceral fat to energy crashes body weight alone won't reveal.
Sep 30, 2026
Short interest
Short Interest: MED down 43% to 1.1M shares
Settlement 2026-09-30 | Days to cover: 7.30 | ≈9.42% of shares outstanding (est.)

SecBot reports

8 filings · 7 press releases · 3 bullish · 1 bearish · 4 neutral
All MED filing & press-release reports (15)